Pamela J. Cramer, Chief Human Resources Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 27,628 shares at $75.55 ($2.1M) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($2.1M) by Chief Human Resources Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.55 | 4,225 | $319K | 15.1% |
| 2 | $75.55 | 4,225 | $319K | 15.1% |
| 3 | $76.69 | 7,831 | $601K | 28.3% |
| 4 | $76.69 | 7,831 | $601K | 28.3% |
| 5 | $80.00 | 3,516 | $281K | 13.3% |
| Total | $76.76 avg | 27,628 |
| $2.1M |
| 100% |
| Filing → |
| RYTM | SELL | 2025-11-12 | $4.2M | — | Filing → |
| RYTM | SELL | 2025-07-29 | $261K | — | Filing → |
| RYTM | SELL | 2025-06-10 | $957K | — | Filing → |